--- title: Buy Nexavar (Sorafenib) 200mg Tabs Online description: Nexavar (Sorafenib) 200mg tablets treat liver, kidney, and thyroid cancers. Get authentic medication from our secure online pharmacy today. type: product language: en url: https://liabilis.com/order-nexavar-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 224.99 price_max: 827.99 currency: USD offers: - name: 200mg x 30 tabs price: 224.99 - name: 200mg x 60 tabs price: 425.99 - name: 200mg x 90 tabs price: 629.99 - name: 200mg x 120 tabs price: 827.99 --- # Buy Nexavar (Sorafenib) 200mg Tabs Online Nexavar, with Sorafenib and developed by Bayer, is a multikinase inhibitor for hepatocellular carcinoma, renal cell carcinoma, and thyroid cancer. It targets tumor cell proliferation and angiogenesis in adults. Available as 200mg tabs from our trusted online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **200mg** | 30 tabs | **$224.99** | $7.50 | In Stock | | **200mg** | 60 tabs | **$425.99** | $7.10 | In Stock | | **200mg** | 90 tabs | **$629.99** | $7.00 | In Stock | | **200mg** | 120 tabs | **$827.99** | $6.90 | In Stock | [Buy Now](https://liabilis.com/order-nexavar-online-en.html) ## Introduction Nexavar is a tablet formulation that contains the active ingredient sorafenib, a small-molecule kinase inhibitor. It is supplied as 200 mg tablets and belongs to the class of oral multikinase inhibitors used in oncology. The medication is primarily indicated for certain advanced solid tumors, with additional off-label investigations in other cancer types. --- ## Quick Reference Facts **Active Ingredient** : sorafenib **Form** : tablet 200 mg **Primary and Off-Label Uses** : • Advanced renal cell carcinoma (RCC) : • Unresectable hepatocellular carcinoma (HCC) : • Differentiated thyroid carcinoma (off-label) : • Gastrointestinal stromal tumors (off-label) --- ## What is Nexavar? Nexavar is the generic version of medications containing the active compound sorafenib. It is classified as an oral multikinase inhibitor that targets several signaling pathways involved in tumor growth and angiogenesis. Sorafenib was originally discovered by Bayer AG and brought to market under the brand name Nexavar. Generic formulations are chemically identical to the brand product and must meet the same regulatory standards for bioequivalence, safety, and efficacy. Because Nexavar is a generic, it offers the same therapeutic effect as the branded version while typically costing less. --- ## How Nexavar Works Sorafenib inhibits multiple intracellular kinases, including RAF kinases (CRAF, BRAF), vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3), platelet-derived growth factor receptor beta (PDGFR-β), and other tyrosine kinases. By blocking these pathways, the drug reduces tumor cell proliferation and impairs the formation of new blood vessels needed for tumor nourishment. After oral administration, sorafenib is absorbed with a bioavailability of roughly 38 % and reaches peak plasma concentrations in about 2-3 hours. It is extensively metabolized in the liver by CYP3A4 and UGT1A9, and the metabolites are eliminated primarily via feces. The half-life is approximately 25-48 hours, supporting a once-daily dosing schedule. Because the drug is processed by hepatic enzymes, concomitant medications that affect CYP3A4 activity can alter sorafenib exposure. --- ## Conditions Treated with Nexavar - **Advanced renal cell carcinoma (RCC)** Sorafenib blocks angiogenic signaling that is critical for the growth of clear-cell RCC, prolonging progression-free survival in patients who have progressed after prior therapy. - **Unresectable hepatocellular carcinoma (HCC)** In HCC, inhibition of VEGF and RAF pathways curtails tumor vascularization and cell growth, providing a survival benefit compared with placebo in large phase-III studies. - **Differentiated thyroid carcinoma (off-label)** Although not formally approved, sorafenib’s activity against RET and VEGFR has shown tumor-size reduction in patients with progressive, radioactive-iodine-refractory disease. - **Gastrointestinal stromal tumor (off-label)** The drug’s multikinase inhibition can affect KIT-driven pathways, offering an alternative for patients who are intolerant to first-line tyrosine-kinase inhibitors. --- ## Is Nexavar the Right Medication for You? - **Suitable patients** Adults with confirmed advanced RCC or unresectable HCC who have measurable disease and adequate organ function are typical candidates. The drug is also considered for patients with progressive differentiated thyroid carcinoma when other options have failed. - **Clinical scenarios favoring Nexavar** When disease progression occurs after first-line VEGF-targeted therapy, or when patients cannot tolerate more intensive chemotherapy, sorafenib provides an oral, outpatient option. - **Contraindications and cautions** Patients with severe hepatic impairment (Child-Pugh C), uncontrolled hypertension, or known hypersensitivity to sorafenib should not receive Nexavar. Caution is advised in those with cardiac ischemia, QT prolongation, or who are on strong CYP3A4 inducers or inhibitors. - **Special populations** Dose adjustments are required for mild to moderate liver dysfunction; use in pregnancy is contraindicated because of teratogenic risk. Breast-feeding mothers should avoid the medication. --- ## Buying Nexavar from [our online pharmacy](https://liabilis.com/order-nexavar-online-en.html) ### Why Choose Our Service? Our platform connects patients with affordable, high-quality generic oncology medicines, helping to reduce the financial burden often associated with cancer treatment. By sourcing from vetted suppliers, we simplify access while maintaining strict privacy standards. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Nexavar is verified against regulatory specifications for potency, purity, and labeling before shipment. ### Pricing & Access Generic sorafenib tablets are offered at a price that approaches the manufacturer’s cost, delivering significant savings compared with the branded product. This enables patients in regions with limited insurance coverage to obtain essential therapy without prohibitive expense. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident containers and dispatched with express shipping that typically arrives within 7 days or standard airmail in roughly 3 weeks. Privacy is maintained throughout the fulfillment process. --- ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** The usual adult dose is one 200 mg tablet taken orally twice daily (total 400 mg per day) on an empty stomach, at least 1 hour before or 2 hours after a meal. - **Missed dose** If a dose is forgotten and more than 6 hours have elapsed, skip the missed tablet and resume the regular dosing schedule. Do not double-dose to compensate. - **Overdose** In the event of a suspected overdose, seek immediate medical attention. Symptoms may include severe nausea, vomiting, diarrhea, or cardiac arrhythmias. Supportive care and activated charcoal may be administered by clinicians. - **Practical precautions** Avoid concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole) or inducers (e.g., rifampin) without physician guidance. Limit alcohol intake, as it can exacerbate hepatic toxicity. Refrain from operating heavy machinery if you experience dizziness or visual disturbances. --- ## Safety Information ### ⚠️ Who Should Not Take Nexavar - Patients with severe hepatic impairment (Child-Pugh C) - Individuals with known hypersensitivity to sorafenib or any tablet excipients - Women who are pregnant or may become pregnant without effective contraception ### Common Side Effects - **Hand-foot skin reaction** (redness, swelling on palms/soles) - occurs in up to 30 % of patients; moisturizers and dose interruptions help manage it. - **Diarrhea** - generally mild to moderate; loperamide is effective for control. - **Hypertension** - monitor blood pressure weekly; antihypertensives may be required. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe bleeding** (gastrointestinal or intracranial) - stop medication and call emergency services. - **Cardiac ischemia or myocardial infarction** - chest pain, shortness of breath, or palpitations constitute an emergency. - **Severe liver injury** - symptoms include jaundice, dark urine, or upper-right abdominal pain; discontinue drug promptly. ### Drug & Food Interactions - **CYP3A4 inhibitors (e.g., itraconazole, erythromycin)** - increase sorafenib plasma levels; dose reduction may be necessary. - **CYP3A4 inducers (e.g., carbamazepine, St. John’s wort)** - reduce drug exposure, potentially lowering efficacy. - **Anticoagulants (warfarin, direct oral anticoagulants)** - heightened risk of bleeding; monitor coagulation parameters closely. - **Antacids** - may alter absorption; separate administration by at least 2 hours. --- ## Off-Label and Investigational Uses of Nexavar - **Radioactive-iodine-refractory differentiated thyroid carcinoma** - small-scale studies have reported partial responses and disease stabilization, prompting investigation in phase-II trials. - **Advanced melanoma** - sorafenib has been examined in combination with immune checkpoint inhibitors, showing modest activity but increased toxicity. - **Metastatic pancreatic cancer** - early-phase research suggests potential benefit when paired with gemcitabine, though data remain preliminary. These applications have not received regulatory approval; they should only be pursued within a clinical trial or under specialist supervision. --- ## Storage & Handling - **Temperature** - Store tablets at 20-25 °C (68-77 °F); excursions permitted between 15-30 °C. - **Light & humidity** - Keep in the original container, away from excess moisture and direct sunlight. - **Expiry** - Do not use beyond the printed expiration date; discard any tablets that appear discolored or damaged. - **Disposal** - Return unused medication to a pharmacy-based take-back program or follow local hazardous-waste guidelines. --- ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Nexavar tablets?** Yes, but carry a copy of the prescription and a doctor’s note if required by customs. Keep the medication in its original container and store it at room temperature throughout the trip. - **Should I take Nexavar with food?** Sorafenib absorption is reduced by food, so the tablets should be taken on an empty stomach-at least 1 hour before or 2 hours after meals. - **Is it safe to drink alcohol while on Nexavar?** Moderate alcohol consumption may increase liver toxicity. Discuss your drinking habits with your oncologist to determine a safe limit. **Product & Formulation Details** - **What do Nexavar tablets look like?** The generic 200 mg tablets are round, white to off-white, and bear the imprint “200 MG” on one side. Appearance can vary slightly between manufacturers. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with severe lactose intolerance should consult a pharmacist. **Regulatory & Safety Nuances** - **Will Nexavar show up on a standard drug test?** Sorafenib is not typically screened for in employment-related drug testing panels, which focus on substances of abuse. - **Can elderly patients safely use Nexavar?** Older adults may have reduced hepatic function and higher susceptibility to hypertension and hand-foot skin reactions; dose adjustments and close monitoring are recommended. **Scientific & Clinical Curiosity** - **What was the key trial that led to sorafenib’s approval?** The SHARP trial (Sorafenib Hepatocellular Carcinoma Assessment Protocol) demonstrated a median overall survival benefit of 2.8 months versus placebo in unresectable HCC, forming the basis for regulatory approval. - **How does sorafenib differ from newer kinase inhibitors?** Sorafenib targets a broader spectrum of kinases but is less selective than agents such as lenvatinib or cabozantinib, which may translate into distinct efficacy and toxicity profiles. --- ## Glossary **Multikinase inhibitor** : A drug that simultaneously blocks several protein kinases involved in tumor growth and blood vessel formation. **Hand-foot skin reaction** : A dermatologic toxicity characterized by redness, swelling, and pain on the palms and soles, commonly associated with certain targeted cancer therapies. **CYP3A4** : An enzyme in the liver that metabolizes many medications; its activity influences the plasma concentration of sorafenib. **Child-Pugh classification** : A scoring system that assesses the severity of chronic liver disease, guiding dosing and safety decisions for hepatically cleared drugs. **Bioequivalence** : The condition wherein a generic product demonstrates the same rate and extent of absorption as the reference brand product. --- ## Disclaimer The details presented about Nexavar are intended for general educational purposes and do not replace professional medical consultation. All therapeutic decisions, including those concerning off-label applications, should be made under the direct supervision of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. Our pharmacy service offers access to Nexavar for individuals who encounter limited availability through conventional channels or who are seeking cost-effective generic alternatives. Always discuss any medication changes with your physician before initiating, altering, or discontinuing therapy.